Short description
Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.
–
ATC Code: J01DH02,
Generic Name: Meropenem,
Pharmaceutical form: Injection and Infusion Fluid,
Strength: 500 mg,
Pack size: Vial,
Unit: 3 g,
Quantity in units: Denmark: 5.578, Iceland: 433, Norway: 2.000.
ATC Code: J01DH02,
Generic Name: Meropenem,
Pharmaceutical form: Injection and Infusion Fluid,
Strength: 1000 mg,
Pack size: Vial,
Unit: 3 g,
Quantity in units: Denmark: 176.842, Iceland: 11.000, Norway: 60.000.
Under the title "Quantity in units", an estimated consumption of the pharmaceuticals is indicated for each of the countries. It should be noted that this estimate corresponds to the historical consumption of the pharmaceuticals put up for tender and that suppliers must expect that the actual purchase under a framework agreement may deviate significantly from the estimate. Reference is made to paragraph 5.6 of the tender specifications and clause 4.2 in the framework agreement.